and osteoclasts (Johnston et al. 1968) , and it has been suggested that some cases may be primarily due to overprod-uction of bone rather than to decreased resorption (Manzke et al. 1982) . The generalized increase in bone scan activity with absent renal uptake in our patient further confirms that osteopetrosis is sometimes related to increased bone turnover.
This case therefore demonstrates the presence of Paget's disease as a hitherto unknown complication of benign osteopetrosis in a young adult, and shows features suggesting that, in some cases at least, osteopetrosis is caused by increased turnover of bone. The association with Crohn's disease in two family members implies that this disease may also be linked with osteopetrosis. Case report A 26-year-old housewife presented with abdominal swelling and diarrhoea following an episode of vomiting five weeks after the normal delivery of her second child. The pregnancy had been free from complication. She was taking no medication except inhaled salbutamol for asthma and there was no previous history of liver disease. On examination she looked ill and had gross ascites with minimal ankle oedema. The liver and spleen were not palpable and the remainder of the examination was normal. Apart from mild hyponatraemia at 133 mmol/l (normal 135-145), urea and electrolytes were normal. Serum bilirubin was elevated at 27 Lmol/l (normal 3-18), albumin was low at 27 g/l (normal 35-45) and prothrombin time was prolonged to 17 seconds. Alanine and aspartate aminotransferases and alkaline phosphatase were normal. Urinary volume was consistently less than 400 ml per day despite treatment with spironolactone and frusemide, with diminished renal sodium excretion (< 5 mmol/l).
Ultrasound scan could not show any patent hepatic veins but, significantly, a recanalized umbilical vein was seen. The main portal vein and inferior vena cava were patent. There was gross ascites and mild hepatomegaly and splenomegaly.
A 99mTc colloid isotope scan showed markedly reduced hepatic uptake with some central sparing in the region of the caudate lobe. Portal contribution to hepatic blood flow, as assessed by the method of Ferguson et al. (1981) , was also measured during the study and was zero. The diagnosis of hepatic vein thrombosis was made from these two studies, and from hepatic aortography with digital subtraction views of the hepatic veins.
Three weeks after the onset of her illness she was given three intravenous doses of acylated streptokinase-plasminogen complex (BRL 26921) accompanied by 100mg hydrocortisone at intervals of eight hours. The first two injections were of 10 mg and the third was reduced to 5 mg because of prolongation of the thrombin clotting time beyond 300 seconds without clotting occurring and a plasma fibrinogen of 50 mg (100 ml). Immediately following the first dose she developed an episode of mild wheezing lasting seven minutes which responded to inhaled salbutamol and to chlorpheniramine. There was no abnormal bleeding or microscopic haematuria. Three days after the first injection a heparin infusion was commenced and the activated partial thromboplastin time was maintained at 2.5 times normal. After a further 17 days anticoagulation was changed to warfarin. The haematological response to therapy is shown in Table 1 . Five days after starting therapy there was a sudden rise in urinary volume to 1.31/24 hours and in urinary sodium to 163mmol/l and the ascites diminished so that by 10 days she had lost 10 kg body weight. By 15 days ascites was no longer detectable clinically or by ultrasound examination but she had 4cm splenomegaly. Nine months later the patient is asymptomatic although the splenomegaly persists. Liver function tests are normal.
Two days after starting treatment the portal venous contribution, as assessed by isotope scanning, had risen to 9% and after 22 days to 30%. Nine months later it has reverted to normal at 64%. A 1 cm length of hepatic vein draining into the inferior vena cava was detected by ultrasound on the 5th day after treatment and by the 15th day small hepatic veins could be detected, which became more prominent although still of slightly reduced calibre than normal on the 35th day.
Discussion
Thrombolytic therapy for Budd-Chiari syndrome has generally been abandoned because of the high risk of haemorrhagic complications in patients with liver disease, despite some early encouraging reports (Warren et al. 1972 , Cassel & Morley 1974 , and it has recently been concluded that hepatic transplantation is the only useful form of treatment (Powell-Jackson et al. 1982) .
The new drug, acylated streptokinaseplasminogen complex, has the advantage of producing thrombolysis without the hazards of excessive defibrinogenation (Prowse et al. 1982) . The haematological results in our patient (Table 1) confirm this, in that fibrin degradation products rose after 12 hours whereas the serum fibrinogen titre did not fall significantly.
Whilst limited inferences can be made from a single case, the rapid clinical recovery which followed the start of treatment in a patient previously deteriorating suggests that the drug was responsible for the patient's recovery. In particular, the absence of haemorrhagic complications suggests that acylated streptokinase-plasminogen complex merits further trial in this condition.
